SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 155 filers reported holding SAGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,920,000 | -16.1% | 269,010 | +7.6% | 2.78% | -6.8% |
| Q2 2021 | $14,203,000 | -50.3% | 250,000 | -34.6% | 2.98% | -49.6% |
| Q1 2021 | $28,599,000 | -27.3% | 382,085 | -15.9% | 5.91% | -7.4% |
| Q4 2020 | $39,312,000 | -67.3% | 454,417 | -76.9% | 6.38% | -41.0% |
| Q3 2020 | $120,204,000 | +37.5% | 1,966,688 | -6.5% | 10.81% | +54.7% |
| Q2 2020 | $87,416,000 | +66.8% | 2,102,368 | +15.2% | 6.99% | +27.6% |
| Q1 2020 | $52,399,000 | -8.8% | 1,824,479 | +129.2% | 5.48% | +9.4% |
| Q4 2019 | $57,467,000 | +1053.5% | 796,057 | +1430.9% | 5.00% | +694.3% |
| Q4 2018 | $4,982,000 | -84.9% | 52,000 | -74.0% | 0.63% | -88.8% |
| Q4 2017 | $32,942,000 | +382.9% | 200,000 | +82.6% | 5.62% | +323.6% |
| Q3 2017 | $6,822,000 | -71.0% | 109,500 | -62.9% | 1.33% | -68.5% |
| Q2 2017 | $23,525,000 | -45.0% | 295,400 | -50.9% | 4.21% | -50.4% |
| Q1 2017 | $42,771,000 | +117.2% | 601,809 | +56.0% | 8.49% | +109.9% |
| Q4 2016 | $19,693,000 | +61.4% | 385,683 | +45.6% | 4.05% | +30.1% |
| Q3 2016 | $12,198,000 | +22.7% | 264,893 | -19.7% | 3.11% | +9.3% |
| Q2 2016 | $9,943,000 | – | 330,000 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |